Liem, Ma, Booked and Busy: 2C-B's Rise as a Recreational Designer Drug

2C-B, also known as 4-bromo-2,5-dimethoxyphenethylamine or by names such as Nexus or Erox, is a psychedelic drug of the phenethylamine and 2C families. The drug is used as a recreational drug and is usually taken orally. 2C-B produces hallucinogenic, mild stimulant, and mild entactogenic-like effects. Its hallucinogenic effects at typical doses are milder than those of other psychedelics like LSD or psilocybin. The drug acts as a potent partial agonist of the serotonin 5-HT2 receptors, including of the serotonin 5-HT2A receptor. It produces psychedelic-like effects in animals. Numerous analogues and derivatives of 2C-B are known, such as DOB, 2C-B-FLY, and 25B-NBOMe among others. 2C-B was developed by Alexander Shulgin in 1974 and was described by him in the scientific literature in 1975. The drug also emerged as a novel recreational designer drug and MDMA (ecstasy) substitute in the mid-1980s. Subsequently, it became a controlled substance in the United States in 1995. The rise of 2C-B as a recreational designer drug has been linked to its availability online and in certain communities. According to a study published in the Journal of Psychopharmacology, 2C-B has been used by individuals seeking a 'legal high' due to its similarity to other controlled substances. However, the use of 2C-B has been associated with adverse effects, including anxiety, panic, and psychosis. The long-term consequences of 2C-B use are not well understood, and further research is needed to determine its safety and efficacy. The emergence of 2C-B as a recreational designer drug highlights the ongoing challenge of regulating and controlling the production and distribution of psychoactive substances. As a result, law enforcement agencies and health organizations have increased efforts to educate the public about the risks associated with 2C-B use. For more information on 2C-B, see the Wikipedia article on 2C-B and the Journal of Psychopharmacology study.

The rise of 2C-B as a recreational designer drug has significant cultural and societal implications. The drug's emergence in the mid-1980s coincided with the growing popularity of rave culture and the club scene. As a result, 2C-B became associated with the 'party' and 'rave' communities, where it was often used as a substitute for MDMA (ecstasy). The use of 2C-B in these contexts highlights the ongoing challenge of regulating and controlling the production and distribution of psychoactive substances. According to a study published in the Journal of Psychopharmacology, 2C-B has been used by individuals seeking a 'legal high' due to its similarity to other controlled substances. However, the use of 2C-B has been associated with adverse effects, including anxiety, panic, and psychosis. The long-term consequences of 2C-B use are not well understood, and further research is needed to determine its safety and efficacy. As a result, law enforcement agencies and health organizations have increased efforts to educate the public about the risks associated with 2C-B use. For more information on 2C-B, see the Wikipedia article on 2C-B.